It is well documented that in patients with type 1 diabetes (DM1). decreased levels of angiogenin are associated with the development of overt nephropathy. However. little is known about angiogenin levels and subclinical macrovascular organ damage in patients with DM1 and concomitant metabolic syndrome (MS). https://foldlyers.shop/product-category/hdbaset-solutions/